Evaluation of BRIP-1 and FANCI Protein Expression in Ovarian Cancer Tissue
Author Information
Author(s): Kozłowski Mateusz, Borzyszkowska Dominika, Golara Anna, Durys Damian, Piotrowska Katarzyna, Kempińska-Podhorodecka Agnieszka, Cymbaluk-Płoska Aneta, Di Agostino Silvia, Rago Vittoria, Perri Anna
Primary Institution: Pomeranian Medical University in Szczecin
Hypothesis
The study aims to evaluate the expression of BRIP-1 (FANCJ) and FANCI proteins in ovarian cancer tissue and assess these expressions in differentiating clinical features.
Conclusion
FANCI protein is associated with lower FIGO stage and histologically high-grade cancer in ovarian cancer.
Supporting Evidence
- FANCI protein showed moderate to strong positive expression in ovarian cancer tissues.
- Lower expression of FANCI and BRIP-1 was associated with differences in clinical stage of HGSOC.
- Patients with lower BRIP-1 expression showed differences in menopausal status.
Takeaway
This study looked at two proteins in ovarian cancer tissues to see if they can help tell how serious the cancer is. They found that one protein, FANCI, is linked to less severe cancer stages.
Methodology
The study was retrospective, involving immunohistochemical evaluation of protein expression in formalin-fixed paraffin-embedded ovarian cancer tissue samples from 68 patients.
Limitations
The small sample size may limit the statistical significance of the findings.
Participant Demographics
Patients were divided into high-grade serous ovarian cancer (HGSOC) and non-HGSOC groups, with a median age of 61 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website